UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 15, 2018
Accession Number:
0001104659-18-016499
Submission Type:
POS AM
CIK:
0001634432
Company Name:
Strongbridge Biopharma plc
File Number:
333-215531